Prognostic Value of DNA-Ploidy in Colorectal Cancer
Author Information
Author(s): M. Kouril, S. Pyrhbnenl, J.-P. Mecklin, H. Jiirvinen, A. Laasonen, K. Franssila, S. Nordling
Primary Institution: Helsinki University Central Hospital
Hypothesis
Does DNA-ploidy provide prognostic information in colorectal carcinoma?
Conclusion
DNA-aneuploidy is associated with poorer prognosis in patients with stage A-C colorectal cancer.
Supporting Evidence
- 68% of tumors showed an abnormal DNA stemline.
- Patients with aneuploid tumors had a worse prognosis than those with diploid or tetraploid tumors.
- SPF did not correlate with prognosis.
Takeaway
This study looked at 157 patients with colorectal cancer and found that those with abnormal DNA patterns had worse outcomes.
Methodology
Patients were analyzed for DNA-ploidy, DNA-index, and S-phase fraction using flow cytometry.
Limitations
The study excluded patients with a history of cancer and those with cancer family syndrome.
Participant Demographics
Patients included 83 males and 74 females, with ages ranging from under 60 to over 70.
Statistical Information
P-Value
P = 0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website